Phase I-II

Creative clinical solutions come through in tough times: webinar

18-Mar-2021 By Jenni Spinner

With COVID-19 adding challenges to the already complex field, the April 6 Clinical Development Innovations webinar will share thoughtful solutions.

FDA current COVID-19 updates, actions and advice

17-Mar-2021 By Jenni Spinner

As the vaccine goes into the arms of more people around the country, the US agency keeps on top of issues around the virus, offering resources and guidance.

Saama, Oracle partner on integrated clinical trial technology

16-Mar-2021 By Jenni Spinner

Saama’s range of Smart applications will be integrated with the Oracle Health Sciences Clinical One platform to help users accelerate drug development.

Gilead, Merck to team up on potential HIV combo treatment

16-Mar-2021 By Jenni Spinner

The two major pharmaceutical firms have agreed to jointly develop and commercialize treatment combinations of lenacapavir and islatravir in HIV patients.

Home health monitoring provides valuable patient insights: Current Health

15-Mar-2021 By Jenni Spinner

A leader from the trial solutions provider discusses how the COVID-19 pandemic has accelerated the already growing interest in remote patient monitoring.

GSK expands its clinical trial manufacturing capacity at dedicated CGT facility in UK

15-Mar-2021 By Jane Byrne

Cell and Gene Therapy Catapult (CGT Catapult) says that GSK will leverage its Stevenage facility to perform GMP cell processing and accelerate its cell and gene therapy pipeline for clinical trials.

IQVIA announces growth in Orchestrated Customer Engagement solution

15-Mar-2021 By Jenni Spinner

The Orchestrated Customer Engagement Technology reportedly has been adopted by 140 life sciences companies (including top-10 pharma firms) in nearly 90 countries.

Report reveals gap between rare-disease drug spending, need

11-Mar-2021 By Jenni Spinner

The IQVIA and NORD study shows rare-disease treatments account for only 11% of new drug spending, but 80% of orphan products treat rare diseases alone.

Thermo Fisher Scientific expands DTP trial service offerings

11-Mar-2021 By Jenni Spinner

The direct-to-patient service is designed to support trials and help to minimize trial length and costs, while boosting enrollment and participation rates.

Setback for Novartis drug in advanced lung cancer trial

09-Mar-2021 By Jane Byrne

Novartis reported today that a clinical trial of the drug, known as canakinumab, when combined with chemotherapy agent, docetaxel, failed to extend the lives of patients with advanced or metastatic non-small cell lung cancer compared to just chemotherapy...

Valneva and Pfizer start new Phase 2 study for Lyme disease vaccine candidate

08-Mar-2021 By Rachel Arthur

Valneva and Pfizer have initiated a Phase 2 study for their Lyme disease vaccine candidate: which is the only active Lyme disease vaccine in clinical development today.

ObvioHealth announces upgraded decentralized trial platform

08-Mar-2021 By Jenni Spinner

The company’s technology facilitates remote patient monitoring and integrates with a wide range of wearable sensors for checking patient vital signs.

US Army taps PPD to conduct PTSD treatment research

04-Mar-2021 By Jenni Spinner

The CRO will receive funding to fuel a five-year Research Project Award, with the goal to design and conduct research of potential PTSD treatment options.

Inside the Pfizer/BioNTech COVID-19 vaccine trial: ‘We knew the world was watching and waiting for results’

03-Mar-2021 By Rachel Arthur

The 2020 Pfizer/BioNTech COVID-19 vaccine trial recruited more than 44,000 participants and reached submission for emergency authorization in 248 days: showing unprecedented speed and agility in the context of a global pandemic. So what have been the...

Prostate cancer drug demonstrates major survival benefit

02-Mar-2021 By Jenni Spinner

According to Noxopharm, a recent study shows combining its Veyonda drug and a radiopharmaceutical yields favorable results against prostate cancer.

Vocal biomarkers enable unique diagnosis, monitoring capabilities

02-Mar-2021 By Jenni Spinner

A leader from Vocalis Health explains how health data can be culled from patient voice recordings to screen and monitor COVID-19 and other conditions.

SCOPE 2021

Shimmer launches upgraded wearable for remote patient monitoring

02-Mar-2021 By Jenni Spinner

The Verisense Pulse+ can measure heart rate, oxygen saturation, emotional responses, and activity and sleep levels of at-home clinical trial participants.

RARE DISEASE DAY

Genetic services can overcome rare disease trial challenges: InformedDNA

01-Mar-2021 By Jenni Spinner

A leader from the genetic solutions firm explains how genetic testing and counseling can help trial teams form more beneficial connections with patients.

Syneos, Protocol First to collaborate on trial data solutions

01-Mar-2021 By Jenni Spinner

The partnership reportedly will center on optimizing integration for EHR data and remote-source data review to help accelerate clinical research results.

ICON to acquire PRA Health Sciences in $12b deal

25-Feb-2021 By Jenni Spinner

The deal consolidates two significant players in the contract research organization arena, in a deal reportedly worth approximately $12b USD.

RARE DISEASE DAY

Patient-centric approach key to rare disease research: Centogene

25-Feb-2021 By Jenni Spinner

A leader from the genetics diagnostic solutions company explains how putting the patient first can make the difference in orphan drug development.

RARE DISEASE DAY

Community building empowers rare-disease patients: Xperiome

25-Feb-2021 By Jenni Spinner

An executive from the rare disease technology solutions company discusses how forcing connections with patients can boost research into such conditions.

SCOPE 2021

COVID-19 elevates appreciation, use of RBQM: CluePoints

25-Feb-2021 By Jenni Spinner

A leader from the risk-based quality management solutions provider will discuss the growing interest in the technology, during this year’s SCOPE event.

SCOPE 2021

Trust, transparency aided COVID-19 vaccine partnership: Praxis

24-Feb-2021 By Jenni Spinner

A leader from Praxis explains how the firm worked with Moderna on patient recruitment strategy and other solutions in the road to launching a vaccine.

SCOPE 2021

Direct data capture a 'game changer' for trials: Clinical Ink

24-Feb-2021 By Jenni Spinner

An executive from the clinical trial technology provider will share how direct data capture can save time, avoid errors and improve the patient experience.

SCOPE 2021

In-home services boost patient centricity: Firma Clinical

24-Feb-2021 By Jenni Spinner

A leader from the global research services company shares how in-home services maximize patient convenience and COVID-19's impact on clinical studies.

SCOPE 2021

SCOPE 2021 to take on tough clinical trial challenges

24-Feb-2021 By Jenni Spinner

The annual event, moved to the virtual realm thanks to COVID-19, offers content on remote monitoring, drug development technology and other key topics.

Cerba Research, Biokortex forge patient-data partnership

23-Feb-2021 By Jenni Spinner

The collaboration will leverage patients’ biological and medical data to streamline patient identification and recruitment efforts in clinical research.

Rho CRA shares her perspectives on COVID-19’s impact

22-Feb-2021 By Jenni Spinner

A senior clinical research associate from the CRO discusses how the pandemic has touched her workday, and how she is dealing with the myriad challenges.

Medidata introduces Sensor Cloud wearables platform

22-Feb-2021 By Jenni Spinner

The technology is designed to streamline and simplify integration, data collection and analysis, and digital biomarker discovery with wearable sensors.

Decentralized trials more pandemic-proof than traditional: study

16-Feb-2021 By Jenni Spinner

A study by two trial technology firms reportedly indicates that decentralized trials are outperforming on-site in recruitment, retention and other aspects.

AstraZeneca/Oxford to trial COVID-19 vaccine in children

15-Feb-2021 By Rachel Arthur

A new trial for the AstraZeneca/Oxford COVID-19 vaccine will investigate the efficacy of the vaccine in children aged six and over.

Latest FDA COVID-19 updates and activity

09-Feb-2021 By Jenni Spinner

The federal agency continues to keep researchers, pharma firms and citizens apprised of current happenings and research related to the virus and pandemic.

Remote monitor streamlines blood pressure data collection

08-Feb-2021 By Jenni Spinner

Smart Meter’s iBloodPressure monitor enables automatic transmittal of results without docking stations, WiFi, syncing, apps or smartphones.

eCOA solutions can’t afford to overlook user experience: YPrime

08-Feb-2021 By Jenni Spinner

According to a company leader, electronic clinical outcome assessment solutions should take ease of use for patients, sponsors and others into account.

World Cancer Day

Super Bowl player donates to help fund cancer research

04-Feb-2021 By Jenni Spinner

William Gholston, with the Tampa Bay Buccaneers football team, is donating to the Moffitt Cancer Center to fund research into cancer treatment disparities.

World Cancer Day

Family cancer experience informs eHealth company

04-Feb-2021 By Jenni Spinner

The founder of Andaman7’s leukemia diagnosis, and his son’s experience with bone cancer, have helped inform the firm's tech and patient-centric approach.

Elligo hits 100-million patient mark with network

02-Feb-2021 By Jenni Spinner

Thanks to collaborations with Cerner, amassing of proprietary data and other achievements, the trial solutions firm has hit a significant access milestone.

Oracle, Cognizant alliance aims to accelerate study startups

02-Feb-2021 By Jenni Spinner

The two companies are integrating their technologies in a move designed to help hasten trial launches, and get promising new treatments to market faster.

Use of medical imaging in clinical trials expanding

02-Feb-2021 By Jenni Spinner

While the technology has been found mostly in dermatological applications, its use in studies is expanding, according to Illingworth Research Group.

Parexel, Signify join forces to boost trial inclusivity

01-Feb-2021 By Jenni Spinner

The firms will work to develop solutions centered on increasing diversity and inclusivity in clinical research, and addressing healthcare disparities.

Merck Digital Ethics Advisory Panel tackles tech questions

01-Feb-2021 By Jenni Spinner

The panel is intended to address ethical matters that arise around evolving data and digital conduct for all of its various business sectors.

AI-based image redaction guards trial patient privacy

01-Feb-2021 By Jenni Spinner

Bioclinica’s Image Redact AI tool enables trials to edit sensitive information from videos, photos and PDFs to ensure compliance and safeguard patient data

Paradigm4, 54gene collaborate on African clinical data

26-Jan-2021 By Jenni Spinner

With fewer than 3% of analyzed genomes currently coming from Africans, the companies are looking to increase access to and understanding of patient data.

Veeva Systems converts to a public benefit corporation

26-Jan-2021 By Jenni Spinner

While the change signifies the life-sciences solutions firm’s commitment to help customers and patients, day-to-day functions will remain much the same.

Survey reveals patients’ thoughts on trial participation

25-Jan-2021 By Jenni Spinner

Conducted by SubjectWell, the survey of patients with Type 2 diabetes reveals how ethnicity and other factors play a part in trial participation tendencies.

eCOA tech helps trials tackle COVID-19 obstacles: IQVIA

25-Jan-2021 By Jenni Spinner

Two leaders from the clinical technology solutions company discuss how digital tools like eCOAs have been invaluable in facing pandemic-related challenges.

FDA approves injectable treatment for HIV patients

25-Jan-2021 By Jenni Spinner

The agency has given the thumbs up to ViiV’s once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.

Boston University taps Shimmer wearables for brain studies

21-Jan-2021 By Jenni Spinner

The trials, funded by the American Heart Association, will harness the company’s Verisense wearable sensor platform to examine brain-heart health links.

Calyx spins off medical imaging, eClinical solutions firm

19-Jan-2021 By Jenni Spinner

Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward.